4 results match your criteria: "McGill University SMBD Jewish General Hospital[Affiliation]"
J Obstet Gynaecol Can
December 2018
Division of Gynecologic Oncology, McGill University SMBD Jewish General Hospital, McGill University, Montréal, QC. Electronic address:
Objective: This study sought to evaluate the incidence, risk factors, and estimated cost associated with venous thromboembolism (VTE) following robotic surgery for endometrial cancer.
Methods: The study included all consecutive patients with newly diagnosed endometrial cancer who underwent robotic surgery, excluding patients with a previous history of VTE (3%), those taking long-term warfarin (3%), and patients with conversions to laparotomy (3%). The incidence of postoperative symptomatic VTE within 90 days was analyzed.
Cancer Chemother Pharmacol
October 2017
Division of Cardiology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Background: Pegylated liposomal doxorubicin (PLD) is used as a second-line therapy for gynecologic cancers, with a better short-term toxicity profile compared to doxorubicin or other anthracyclines.
Methods: We screened 14 patients with recurrent gynecologic cancers, who underwent prolonged treatment with large cumulative doses of PLD for overt or subtle signs of cardiotoxicity (CTX) using standard and advanced echocardiography techniques [3D volumetric method for left ventricular ejection fraction (LVEF) and left ventricular/right ventricular global longitudinal strain]. Half the patients had previous echocardiographic studies available for comparison.
J Cutan Med Surg
May 2012
McGill University-SMBD Jewish General Hospital, Montreal, QC, Canada.
Background: Bullous lupus erythematosus is a rare disease that is extremely rare in childhood (with only seven previous reports) and difficult to control.
Objective: Herein is presented the youngest patient reported with this condition, and a novel, safe, and effective treatment regimen is described.
Methods: Through study, perseverance, serendipity, and creativity, a safe and effective regimen was developed.
J Robot Surg
December 2010
Division of Gynecologic Oncology, McGill University SMBD Jewish General Hospital, 3755 Cote Ste Catherine Road, Montreal, QC, H3T 1E2, Canada.
To investigate the development of new technical approaches for improving the implementation of robotics in gynaecologic surgery, we conducted a prospective evaluation of five technical modifications developed during the implementation of a robotics program that included 171 robotic endometrial staging procedures from December 2007 until May 2010. Modification of the use of a Hohl uterine manipulator by applying only the intravaginal component minimizes the theoretical risk of spillage of endometrial cancer cells, without losing the capability of delineating the vaginal fornices. Entry to the peritoneal cavity under visual control using a left upper quadrant approach and a 5-mm endoscope through a 5-mm Endopath(®) trocar is quick and decreases the risk of bowel or vessel injury.
View Article and Find Full Text PDF